Cargando…
The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression
Participation of fibrin, fibrinogen, and their degradation products in pathogenesis and progression of cancer may lead to complications of thromboembolic events. The tumor may be a source of fibrinogen. Fibrinogen inside the tumor is one of the factors of its growth and metastasis. Fibrinogen, fibri...
Autores principales: | Kołodziejczyk, Joanna, Ponczek, Michał B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685376/ https://www.ncbi.nlm.nih.gov/pubmed/23788975 http://dx.doi.org/10.5114/wo.2013.34611 |
Ejemplares similares
-
Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges
por: Gaule, Thembaninkosi G., et al.
Publicado: (2021) -
Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation
por: Page, Martin J., et al.
Publicado: (2019) -
Fibrin(ogen) in human disease: both friend and foe
por: Vilar, Rui, et al.
Publicado: (2020) -
Thrombin–Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis
por: Hulshof, Anne-Marije, et al.
Publicado: (2021) -
Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients
por: Xiong, Wei-Xin, et al.
Publicado: (2015)